^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    NCR3LG1 underexpression + TMB-L

    i
    Entrez ID:
    374383
    Related biomarkers:
    Expression
    Others
    almost2years
    Correlation of low B7-H6 expression with efficacy of immunotherapy inpatients with melanoma. (ASCO 2023)
    The low B7-H6 expression was correlated with better efficacy immunotherapy. The effect of B7-H6 expression on immunotherapy needs to be further prospective trial validation.
    Clinical • PD(L)-1 Biomarker • IO biomarker
    |
    TMB (Tumor Mutational Burden) • NCR3LG1 (Natural Killer Cell Cytotoxicity Receptor 3 Ligand 1)
    |
    TMB-H • TMB-L • NCR3LG1 underexpression • NCR3LG1 underexpression + TMB-L